电子邮件 | nog***@***.com | 获取Email |
---|
电子邮件 | nog***@***.com | 获取Email |
---|
Kamada is focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. The Company's flagship product is GLASSIA®, the first liquid, ready-to-use, intravenous plasma-derived AAT product approved by the U.S. Food and Drug Administration. Kamada markets GLASSIA® in the U.S. through a strategic partnership with Baxalta (now part of Shire plc) and in other counties through local distributors. In addition to GLASSIA®, Kamada has a product line of six other pharmaceutical products administered by injection or infusion, that are marketed through distributors in more than 15 countries, including Israel, Russia, Brazil, India and other countries in Latin America and Asia. Kamada's rabies immune globulin (Human) product received FDA approval for Post-Exposure Prophylaxis against rabies infection and is marketed in the U.S. through a partnership with Kedrion Biopharma. Kamada has late-stage products in development, including an inhaled formulation of AAT for the treatment of AAT deficiency and, in addition, its intravenous AAT is in development for other indications, such as type-1 diabetes, GvHD and prevention of lung transplant rejection. Kamada also leverages its expertise and presence in the plasma-derived protein therapeutics market by distributing more than 10 complementary products in Israel that are manufactured by third parties.
公司 | KAMADA |
---|---|
职位 | Clinical Scientist and Medical Manager |
地点 | Israel |
http://www.linkedin.com/in/noga-alagem-a0666a12 | |
部门 | master_engineering_technical,medical_health |
头衔 | Clinical Scientist and Medical Manager |
KAMADA Clinical Scientist and Medical Manager
2021-08-01 -
KAMADA Head of pulmonary medicine and medical writing
2018-11-01 - 2021-08-01
KAMADA Medical Associate
2017-01-01 - 2018-11-01
Medical Manager
2014-07-01 - 2016-12-01
Dot Consulting Director of Biomedical Consulting
2013-06-01 - 2014-07-01
Noga Alagem 在 KAMADA 担任 Clinical Scientist and Medical Manager
Noga Alagem 在 KAMADA 的职位是 Clinical Scientist and Medical Manager
Noga Alagem 的电子邮件地址是 nog***@***.com
Noga Alagem 的电话号码是 -
Noga Alagem 的公司电话号码是 +972****
Noga Alagem 在 pharmaceuticals 工作。
Noga Alagem 的一些同事包括Winston Ally、Avi Tedgi、Kfir Efrati、Yuval HarpazDaliya Enbar、。
Noga Alagem联系方式: 电子邮件地址:nog***@***.com 电话号码:-
Noga Alagem 的个人领英是:http://www.linkedin.com/in/noga-alagem-a0666a12
Noga Alagem 的办公地点:2 Holzman Street, Rehovot, Tel Aviv District, IL, 7670402
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd